Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $2.01 billion. The enterprise value is $1.42 billion.
| Market Cap | 2.01B |
| Enterprise Value | 1.42B |
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 33.79 million shares outstanding. The number of shares has increased by 39.76% in one year.
| Current Share Class | 33.79M |
| Shares Outstanding | 33.79M |
| Shares Change (YoY) | +39.76% |
| Shares Change (QoQ) | +21.87% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 66.64% |
| Float | 29.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.06 |
| Forward PS | 47.95 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 3.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.21, with a Debt / Equity ratio of 0.25.
| Current Ratio | 10.21 |
| Quick Ratio | 9.92 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.28 |
Financial Efficiency
Return on equity (ROE) is -53.60% and return on invested capital (ROIC) is -173.11%.
| Return on Equity (ROE) | -53.60% |
| Return on Assets (ROA) | -15.28% |
| Return on Invested Capital (ROIC) | -173.11% |
| Return on Capital Employed (ROCE) | -17.67% |
| Weighted Average Cost of Capital (WACC) | 10.95% |
| Revenue Per Employee | $883,063 |
| Profits Per Employee | -$2.51M |
| Employee Count | 63 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -126,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +521.78% in the last 52 weeks. The beta is 1.15, so NKTR's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +521.78% |
| 50-Day Moving Average | 75.19 |
| 200-Day Moving Average | 60.11 |
| Relative Strength Index (RSI) | 32.70 |
| Average Volume (20 Days) | 965,419 |
Short Selling Information
The latest short interest is 4.61 million, so 13.65% of the outstanding shares have been sold short.
| Short Interest | 4.61M |
| Short Previous Month | 4.37M |
| Short % of Shares Out | 13.65% |
| Short % of Float | 15.85% |
| Short Ratio (days to cover) | 5.37 |
Income Statement
In the last 12 months, NKTR had revenue of $55.63 million and -$158.10 million in losses. Loss per share was -$8.09.
| Revenue | 55.63M |
| Gross Profit | 55.63M |
| Operating Income | -124.66M |
| Pretax Income | -158.22M |
| Net Income | -158.10M |
| EBITDA | -123.91M |
| EBIT | -124.66M |
| Loss Per Share | -$8.09 |
Balance Sheet
The company has $568.60 million in cash and $143.43 million in debt, with a net cash position of $588.17 million or $17.41 per share.
| Cash & Cash Equivalents | 568.60M |
| Total Debt | 143.43M |
| Net Cash | 588.17M |
| Net Cash Per Share | $17.41 |
| Equity (Book Value) | 576.22M |
| Book Value Per Share | 19.55 |
| Working Capital | 531.33M |
Cash Flow
In the last 12 months, operating cash flow was -$203.76 million and capital expenditures -$884,000, giving a free cash flow of -$204.64 million.
| Operating Cash Flow | -203.76M |
| Capital Expenditures | -884,000 |
| Depreciation & Amortization | 751,000 |
| Net Borrowing | 273.97M |
| Free Cash Flow | -204.64M |
| FCF Per Share | -$6.06 |
Margins
Gross margin is 100.00%, with operating and profit margins of -224.08% and -284.18%.
| Gross Margin | 100.00% |
| Operating Margin | -224.08% |
| Pretax Margin | -284.41% |
| Profit Margin | -284.18% |
| EBITDA Margin | -222.73% |
| EBIT Margin | -224.08% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.76% |
| Shareholder Yield | -39.76% |
| Earnings Yield | -7.88% |
| FCF Yield | -10.20% |
Analyst Forecast
The average price target for NKTR is $153.25, which is 158.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $153.25 |
| Price Target Difference | 158.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | -5.52% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
NKTR has an Altman Z-Score of -3.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.95 |
| Piotroski F-Score | 3 |